Namyi Gu

915 total citations
44 papers, 703 citations indexed

About

Namyi Gu is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, Namyi Gu has authored 44 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Nutrition and Dietetics. Recurrent topics in Namyi Gu's work include Sodium Intake and Health (10 papers), Blood Pressure and Hypertension Studies (10 papers) and Drug Transport and Resistance Mechanisms (7 papers). Namyi Gu is often cited by papers focused on Sodium Intake and Health (10 papers), Blood Pressure and Hypertension Studies (10 papers) and Drug Transport and Resistance Mechanisms (7 papers). Namyi Gu collaborates with scholars based in South Korea, United States and Taiwan. Namyi Gu's co-authors include Chi-Yeon Lim, Choul Yong Park, Kyung‐Sang Yu, Dong Ju Kim, Moo‐Yong Rhee, In‐Jin Jang, Joo‐Youn Cho, Tae‐Eun Kim, Deuk-Young Nah and Seo Hyun Yoon and has published in prestigious journals such as PLoS ONE, Neuroscience and Molecules.

In The Last Decade

Namyi Gu

43 papers receiving 683 citations

Peers

Namyi Gu
Midori Yatabe Japan
Atsuhiko Takahashi Japan
Barbara Zubelewicz‐Szkodzińska Poland
Márcia Kiyomi Koike Brazil
Avshalom Leibowitz Israel
Elizabeth Fisher Australia
Katarína Gazdíková Slovakia
Niels H. Wacher Mexico
Bogdan Solnica Poland
Katrin Borucki Germany
Midori Yatabe Japan
Namyi Gu
Citations per year, relative to Namyi Gu Namyi Gu (= 1×) peers Midori Yatabe

Countries citing papers authored by Namyi Gu

Since Specialization
Citations

This map shows the geographic impact of Namyi Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Namyi Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Namyi Gu more than expected).

Fields of papers citing papers by Namyi Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Namyi Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Namyi Gu. The network helps show where Namyi Gu may publish in the future.

Co-authorship network of co-authors of Namyi Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Namyi Gu. A scholar is included among the top collaborators of Namyi Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Namyi Gu. Namyi Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Tae‐Eun, et al.. (2024). Research on unintroduced new drugs in South Korea from 2011 to 2020: approaches to prioritization and strategy. Translational and Clinical Pharmacology. 32(4). 187–187.
2.
3.
Jeong, Yun‐Jeong, et al.. (2021). Prospective observational study of the impact of plasma colistin levels in patients with carbapenem-resistant Acinetobacter baumannii pneumonia. Journal of Global Antimicrobial Resistance. 27. 315–323. 1 indexed citations
4.
Rhee, Moo‐Yong, Je Sang Kim, Chee Hae Kim, et al.. (2021). Prevalence and characteristics of isolated nocturnal hypertension in the general population. The Korean Journal of Internal Medicine. 36(5). 1126–1133. 13 indexed citations
5.
Jeong, Hyeon Cheol, et al.. (2021). Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS. Translational and Clinical Pharmacology. 29(4). 226–226. 7 indexed citations
6.
Kang, Sung Wook, Jun Kyu Lee, Dong Kee Jang, et al.. (2019). Quantification of metronidazole in human bile fluid and plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B. 1138. 121959–121959. 11 indexed citations
7.
Oh, Jaeseong, SoJeong Yi, Namyi Gu, et al.. (2018). Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity. Genomics & Informatics. 16(3). 52–58. 6 indexed citations
8.
9.
Yu, Kyung‐Sang, et al.. (2017). A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers. Drug Design Development and Therapy. Volume 11. 1301–1313. 14 indexed citations
10.
Rhee, Moo‐Yong, et al.. (2016). Relationship between 24-h urine sodium/potassium ratio and central aortic systolic blood pressure in hypertensive patients. Hypertension Research. 40(4). 405–410. 7 indexed citations
11.
Rhee, Moo‐Yong, et al.. (2016). Effect of sodium intake on renin level: Analysis of general population and meta-analysis of randomized controlled trials. International Journal of Cardiology. 215. 120–126. 14 indexed citations
12.
Park, Choul Yong, Namyi Gu, Chi‐Yeon Lim, et al.. (2016). The effect of Vaccinium uliginosum extract on tablet computer-induced asthenopia: randomized placebo-controlled study. BMC Complementary and Alternative Medicine. 16(1). 296–296. 21 indexed citations
13.
Gu, Namyi, Min Kyu Park, Tae‐Eun Kim, et al.. (2014). Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers. Drug Design Development and Therapy. 8. 1709–1709. 41 indexed citations
14.
Yu, Kyung‐Sang, Kyung Woo Park, Ronan P. Kelly, et al.. (2013). Pharmacokinetic and Pharmacodynamic Effects of Prasugrel in Healthy Korean Males. Journal of Cardiovascular Pharmacology. 62(1). 72–77. 7 indexed citations
15.
16.
17.
Kim, Tae‐Eun, Namyi Gu, Seo Hyun Yoon, et al.. (2012). Tolerability and Pharmacokinetics of a New P-Glycoprotein Inhibitor, HM30181, in Healthy Korean Male Volunteers: Single- and Multiple-Dose Randomized, Placebo-Controlled Studies. Clinical Therapeutics. 34(2). 482–494. 16 indexed citations
18.
Kim, Sung Eun, Namyi Gu, Bo‐Hyung Kim, et al.. (2012). Pharmacokinetics of Lacosamide in Healthy Korean Male Volunteers. Pharmacology. 89(3-4). 172–178. 9 indexed citations
19.
Kim, Young Eun, Ji Young Yun, Han‐Joon Kim, et al.. (2012). Intravenous Amantadine for Freezing of Gait Resistant to Dopaminergic Therapy: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Clinical Trial. PLoS ONE. 7(11). e48890–e48890. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Midori Yatabe Breakdown of academic impact, for papers by Atsuhiko Takahashi Breakdown of academic impact, for papers by Barbara Zubelewicz‐Szkodzińska Breakdown of academic impact, for papers by Márcia Kiyomi Koike Breakdown of academic impact, for papers by Avshalom Leibowitz Breakdown of academic impact, for papers by Elizabeth Fisher Breakdown of academic impact, for papers by Katarína Gazdíková Breakdown of academic impact, for papers by Niels H. Wacher Breakdown of academic impact, for papers by Bogdan Solnica Breakdown of academic impact, for papers by Katrin Borucki
Rankless by CCL
2026